The mammalian target of rapamycin signaling network and gene regulation
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: The mammalian target of rapamycin (mTOR) is a key integrator of signals from nutrients, energy and insulin. TOR is a protein kinase originally identified in yeast by the genetic selection of rapamycin-resistant mutants. Over the past decade mTOR research has progressed dramatically. Although mTOR is known as a controller of messenger RNA cap-dependent translation initiation, new advances implicate mTOR in the regulation of ribosomal protein gene transcription. The aim of this review is to highlight recent findings on mTOR regulatory networks, focusing on articles published from December 2003 to December 2004. RECENT FINDINGS: mTOR was recently knocked out in mice; the embryonic lethal phenotype demonstrates a critical role of mTOR in early embryo development. Intriguingly, the homozygous deletion of ribosomal protein S6 kinase 1 (S6K1), an mTOR target, in mice results in hypoinsulinemia and glucose intolerance. Despite elevated levels of plasma free fatty acids, S6K1 knockout mice are protected from the metabolic syndrome, indicating a role of S6K1 in glucose homeostasis. Current research indicates that mTOR integrates input from multiple upstream pathways, including insulin, growth factors, nutrients, mitogens and energy. Furthermore, the discovery of mTOR binding partners adds to the intricacies of mTOR as a master switch in cell signaling. SUMMARY: Rapamycin, an mTOR inhibitor, has emerged as an immunosuppressive and antiproliferative drug, and is considered a novel antitumor agent. A better understanding of mTOR signaling would enhance the clinical usefulness of rapamycin and inform consideration of mTOR as a target for the development of new therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093
Phosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling
Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., & Chen, J. (2001) · Science · doi:10.1126/science.1066015 · Cited by 1,055
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010
Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Mammalian TOR: a homeostatic ATP sensor
Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., & Thomas, G. (2001) · Science · doi:10.1126/science.1063518 · Cited by 962
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Gangloff, Y.-G., Mueller, M., Dann, S. G., Svoboda, P., Sticker, M., Spetz, J.-F., Um, S. H., Brown, E. J., Cereghini, S., Thomas, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9508-9516.2004 · Cited by 485
Morrisett, J. D., Abdel-Fattah, G., Hoogeveen, R., Mitchell, E., Ballantyne, C. M., Pownall, H. J., Opekun, A. R., Jaffe, J. S., Oppermann, S., & Kahan, B. D. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m100392-jlr200 · Cited by 295
Cited by
p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326
MORCUENDE, R., BARI, R., GIBON, Y., ZHENG, W., PANT, B. D., BLÄSING, O., USADEL, B., CZECHOWSKI, T., UDVARDI, M. K., STITT, M., et al. (2007) · Plant, Cell & Environment · doi:10.1111/j.1365-3040.2006.01608.x · Cited by 557
The Link between the Metabolic Syndrome and Cancer
Braun, S., Bitton-Worms, K., & LeRoith, D. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1003 · Cited by 326
Roos, S., Jansson, N., Palmberg, I., Säljö, K., Powell, T. L., & Jansson, T. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.129676 · Cited by 283
“In the current study, we show that the protein expression of phosphorylated S6K1, representing activity of the mTOR signalling pathway (Soliman, 2005), is reduced in placentas of human IUGR fetuses.”
BackgroundOhtani, M., Nagai, S., Kondo, S., Mizuno, S., Nakamura, K., Tanabe, M., Takeuchi, T., Matsuda, S., & Koyasu, S. (2008) · Blood · doi:10.1182/blood-2008-02-137430 · Cited by 265
Metadata
- Authors
- Soliman, G. A.
- Venue
- Current Opinion in Lipidology
- Published
- 2005-06
- Volume
- 16
- Issue
- 3
- Pages
- 317-323
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2025687108
- Cited by
- 57
- References
- 10
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The mammalian target of rapamycin signaling network and gene regulation. https://app.cochat.ai/papers/10.1097/01.mol.0000169352.35642.06
- The paper
- Soliman, G. A. (2005). The mammalian target of rapamycin signaling network and gene regulation. Current Opinion in Lipidology. https://doi.org/10.1097/01.mol.0000169352.35642.06
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.